METACARE CO., Ltd. (KRX:118000)

South Korea · Delayed Price · Currency is KRW

1,199.00

0.00 (0.00%)

Last updated: Oct 8, 2026, 3:00 PM KST

Market Cap	26.44B -53.8%
Revenue (ttm)	39.95B +79.9%
Net Income	-1.59B
EPS	-92.00
Shares Out	22.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,788
Open	1,198.00
Previous Close	1,199.00
Day's Range	1,174.00 - 1,236.00
52-Week Range	1,001.00 - 3,780.00
Beta	0.62
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About METACARE CO.

METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founded in 2009 and is headquartered in Hwaseong-si, South Korea. [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 2009

Employees 30

Stock Exchange Korea Stock Exchange

Ticker Symbol 118000

Full Company Profile

Financial Performance

In 2025, METACARE CO.'s revenue was 32.82 billion, an increase of 62.42% compared to the previous year's 20.21 billion. Earnings were 498.24 million, a decrease of -94.14%.

Financial Statements